Posted by Michael Wonder on 15 Sep 2016
The voice of the patient
14 September 2016 - The TGA has published a report of a public meeting held in September last year.
The document is from a series of reports from the U.S. FDA’s patient-focused drug development initiative. The meeting was on the patient-focused drug development of new medicines for patients with alfa-1 anti-trypsin deficiency.
